•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A06554 Summary:

BILL NOA06554
 
SAME ASSAME AS S04639
 
SPONSORGonzalez-Rojas
 
COSPNSRLupardo, Tapia, McDonald, Shimsky, Slater, Smullen, Davila, McDonough, Brown K
 
MLTSPNSR
 
Amd §25.18, Ment Hyg L
 
Relates to reporting on funds received pursuant to a New York opioid settlement sharing agreement.
Go to top

A06554 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A6554
 
SPONSOR: Gonzalez-Rojas
  TITLE OF BILL: An act to amend the mental hygiene law, in relation to funds received pursuant to a New York opioid settlement sharing agreement   PURPOSE OR GENERAL IDEA OF BILL: To increase transparency of funds acquired by the State through the NY Opioid Settlement Sharing Agreement.   SUMMARY OF PROVISIONS: Section 1 amends mental hygiene law to Include funds received pursuant to any NYS opioid settlement sharing agreement in the Opioid Settlement Fund reporting requirements. Section 2 amends the entities listed in mental hygiene law to be internally consistent. Section 3 sets the effective date.   JUSTIFICATION: New York State has successfully received over $2.6 billion through settlements with opioid manufacturers, distributors, and sellers. However, only 36% of those monies are tracked by the NYS Office of Addiction Services and Supports; there is no transparency around the 46% localities' share and 17% State share. Although NY Opioid Settlement Sharing Agreements outline that a certain share of the funds must be spent on approved uses, there is no reporting mechanism to track those funds and ensure they are being spent appropriately. This has led to confusion and mistrust among New Yorkers regarding where the funds are going and how they are being used. This bill expands the existing reporting requirements for the 36% of funds that are In the Opioid Settlement Fund to include the remaining 64% of funds received through a Sharing•Agreement.   PRIOR LEGISLATIVE HISTORY: New bill   FISCAL IMPLICATIONS: TBD   EFFECTIVE DATE: This act shall take effect immediately.
Go to top

A06554 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6554
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                      March 6, 2025
                                       ___________
 
        Introduced  by  M. of A. GONZALEZ-ROJAS -- read once and referred to the
          Committee on Alcoholism and Drug Abuse
 
        AN ACT to amend the mental hygiene law, in relation  to  funds  received
          pursuant to a New York opioid settlement sharing agreement
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Paragraph 10 of subdivision (c) of  section  25.18  of  the
     2  mental  hygiene  law,  as amended by chapter 171 of the laws of 2022, is
     3  amended to read as follows:
     4    10. On or before November first of each year, beginning one year after
     5  the initial deposit of monies in the opioid settlement fund,  the  rele-
     6  vant  commissioners[,]  shall  provide a written report to the governor,
     7  temporary president of the senate, speaker of the assembly, chair of the
     8  senate finance committee, chair of the assembly ways and  means  commit-
     9  tee,  chair of the senate alcoholism and substance [abuse] use disorders
    10  committee, chair of the assembly alcoholism and  drug  abuse  committee,
    11  and the opioid settlement advisory board. Such report shall be presented
    12  as  a  consolidated  dashboard  and  be  made  publicly available on the
    13  respective offices' websites. The report shall, to the extent  practica-
    14  ble  after  making  all  diligent  efforts  to  obtain such information,
    15  include the following: (i) the baseline  funding  for  any  entity  that
    16  receives funding from the opioid settlement fund or other funds received
    17  pursuant to a New York opioid settlement sharing agreement, prior to the
    18  receipt  of  such [opioid settlement] funds; (ii) how funds deposited in
    19  the opioid settlement fund and other funds received pursuant  to  a  New
    20  York  opioid  settlement  sharing  agreement  had  been  utilized in the
    21  preceding calendar year, including but not limited to: (A) the amount of
    22  money disbursed [from the fund] and the  award  process  used  for  such
    23  disbursement,  if  applicable;  (B)  the  names  of  the recipients, the
    24  amounts awarded to such recipient and details  about  the  purpose  such
    25  funds  were  awarded  for, including what specific services and programs
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08762-02-5

        A. 6554                             2
 
     1  the funds were used on and what populations such  services  or  programs
     2  served; (C) the main criteria utilized to determine the award, including
     3  how  the  program  or service assists to reduce the effects of substance
     4  use  disorders;  (D)  an  analysis  of the effectiveness of the services
     5  and/or programs that received opioid settlement funding or  other  funds
     6  received  pursuant  to a New York opioid settlement sharing agreement in
     7  their efforts to reduce the effects of the overdose  and  substance  use
     8  disorder  epidemic.  Such  analysis shall utilize evidence-based uniform
     9  metrics when reviewing the effects the service  and/or  program  had  on
    10  prevention,  harm  reduction,  treatment, and recovery advancements; (E)
    11  any relevant information provided by the New York subdivisions  pursuant
    12  to  this  section;  and (F) any other information the commissioner deems
    13  necessary to help inform future appropriations  and  funding  decisions,
    14  and  ensure  such funding is not being used to supplant local, state, or
    15  federal funding.
    16    § 2.  Subdivision (d) of section 25.18 of the mental hygiene  law,  as
    17  amended  by  chapter  171  of  the  laws  of 2022, is amended to read as
    18  follows:
    19    (d) Limitation on authority of government entities to bring  lawsuits.
    20  No  government entity shall have the authority to assert released claims
    21  against entities released by the department of law in a statewide opioid
    22  settlement agreement executed by the department of law and the  released
    23  party  on or after June first, two thousand twenty-one. Any action filed
    24  by a government entity  after  June  thirtieth,  two  thousand  nineteen
    25  asserting  released  claims  against  a  manufacturer, distributor, [or]
    26  dispenser, consultant, or related  party  thereof,  of  opioid  products
    27  shall  be  extinguished by operation of law upon being released pursuant
    28  to such statewide opioid settlement agreement.
    29    § 3. This act shall take effect immediately.
Go to top